Drug
Sapablursen
Sapablursen: highest development phase Phase 2, developed by Ionis Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| sapablursen NCT05143957 | Phase 2 | Phlebotomy Dependent Polycythemia Vera |
| sapablursen NCT04059406 | Phase 2 | Beta Thalassemia Intermedia |
Latest
No recent events.
Follow Sapablursen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.